HK Stock Market Move | XTALPI (02228) opens nearly 4% higher; subsidiary LCC Technologies enters drug discovery collaboration with Stanford University.

XTALPI (02228) opened nearly 4% higher. As of press time, it was up 3.99% at HK$7.17, with a turnover of HK$4.4597 million. On the news front, XtalPi announced that its wholly-owned subsidiary LCC Technologies has entered into a drug discovery collaboration agreement with Stanford University. The two parties will combine Stanford University's expertise in disease biology research with LCC's small molecule drug discovery platform to jointly evaluate new biological discoveries and explore their potential for further development into small molecule therapeutic drugs. Under the agreement, LCC will work with Stanford University researchers to advance promising research projects and accelerate the progression of related discoveries toward the drug development stage. This collaboration further bridges the translational pathway from disease biology discovery to small molecule drug development, giving cutting-edge scientific discoveries the opportunity to enter the drug development stage more quickly and explore new therapeutic strategies across different disease areas.